Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2
Ian A. McDonald, Sam M. Murray, Catherine J. Reynolds, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 232

Showing 1-25 of 232 citing articles:

Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape
John S. Tregoning, Katie E. Flight, Sophie L. Higham, et al.
Nature reviews. Immunology (2021) Vol. 21, Iss. 10, pp. 626-636
Open Access | Times Cited: 1031
Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus
Betty Raman, David A. Bluemke, Thomas F. Lüscher, et al.
European Heart Journal (2022) Vol. 43, Iss. 11, pp. 1157-1172
Open Access | Times Cited: 526
Efficacy, Immunogenicity and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis
Nadim Sharif, Khalid J. Alzahrani, Shamsun Nahar Ahmed, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 212
COVID-19 vaccination: The road ahead
Daniel M. Altmann, Rosemary J. Boyton
Science (2022) Vol. 375, Iss. 6585, pp. 1127-1132
Closed Access | Times Cited: 180
Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry
Pedro Machado, Saskia Lawson‐Tovey, Anja Strangfeld, et al.
Annals of the Rheumatic Diseases (2021) Vol. 81, Iss. 5, pp. 695-709
Open Access | Times Cited: 167
Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study
Devon E. McMahon, Carrie Kovarik, William Damsky, et al.
Journal of the American Academy of Dermatology (2021) Vol. 86, Iss. 1, pp. 113-121
Open Access | Times Cited: 151
Recent advances in mRNA-LNP therapeutics: immunological and pharmacological aspects
Seyed Hossein Kiaie, Naime Majidi Zolbanin, Armin Ahmadi, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 117
To mix or not to mix? A rapid systematic review of heterologous prime–boost covid-19 vaccination
Nan-Chang Chiu, Hsin Chi, Yu‐Kang Tu, et al.
Expert Review of Vaccines (2021) Vol. 20, Iss. 10, pp. 1211-1220
Open Access | Times Cited: 110
Real-world Effectiveness of the Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S Vaccines Against SARS-CoV-2 in Solid Organ and Islet Transplant Recipients
Chris Callaghan, Lisa Mumford, Rebecca Curtis, et al.
Transplantation (2022) Vol. 106, Iss. 3, pp. 436-446
Open Access | Times Cited: 96
A Systematic Review of Coronavirus Disease 2019 Vaccine Efficacy and Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Disease
Melissa M. Higdon, Brian Wahl, Carli B. Jones, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 6
Open Access | Times Cited: 81
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease
Eleanor Barnes, Carl S. Goodyear, Michelle Willicombe, et al.
Nature Medicine (2023) Vol. 29, Iss. 7, pp. 1760-1774
Open Access | Times Cited: 80
The use of RNA-based treatments in the field of cancer immunotherapy
Mohammad Chehelgerdi, Matin Chehelgerdi
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 75
Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab
Simeng Lin, Nicholas A. Kennedy, Aamir Saifuddin, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 71
Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial
Abhishek Abhishek, Rosemary J. Boyton, Nicholas Peckham, et al.
The Lancet Respiratory Medicine (2022) Vol. 10, Iss. 9, pp. 840-850
Open Access | Times Cited: 70
COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis
Felicia Ceban, Dana Kulzhabayeva, Nelson B. Rodrigues, et al.
Brain Behavior and Immunity (2023) Vol. 111, pp. 211-229
Open Access | Times Cited: 63
Insights into new-onset autoimmune diseases after COVID-19 vaccination
Ming Guo, Xiaoxiao Liu, Xiangmei Chen, et al.
Autoimmunity Reviews (2023) Vol. 22, Iss. 7, pp. 103340-103340
Open Access | Times Cited: 56
mRNA Vaccines against SARS-CoV-2: Advantages and Caveats
Miriam Echaide, Luisa Chocarro, Ana Bocanegra, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5944-5944
Open Access | Times Cited: 51
Acceptance of COVID-19 vaccination at different hypothetical efficacy and safety levels in ten countries in Asia, Africa, and South America
Francesco Rosiello, Samsul Anwar, Amanda Yufika, et al.
Narra J (2021) Vol. 1, Iss. 3
Open Access | Times Cited: 80
Safety, Immunogenicity, and Efficacy of COVID-19 Vaccines in Children and Adolescents: A Systematic Review
Meng Lv, Xufei Luo, Quan Shen, et al.
Vaccines (2021) Vol. 9, Iss. 10, pp. 1102-1102
Open Access | Times Cited: 73
Immunological responses to SARS-CoV-2 vaccines in kidney transplant recipients
Maria Prendecki, Tina Thomson, Candice Clarke, et al.
The Lancet (2021) Vol. 398, Iss. 10310, pp. 1482-1484
Open Access | Times Cited: 65
Concepts in Oncolytic Adenovirus Therapy
Klaus Mantwill, Florian G. Klein, Dongbiao Wang, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10522-10522
Open Access | Times Cited: 62
Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern in real-world: a literature review and meta-analysis
Weihao Shao, Xiaorui Chen, Caifang Zheng, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 2383-2392
Open Access | Times Cited: 62
Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation pattern
Inbal Farkash, Tali Feferman, Noy Cohen Saban, et al.
Cell Reports (2021) Vol. 37, Iss. 11, pp. 110114-110114
Open Access | Times Cited: 61
Acute Transverse Myelitis Following COVID-19 Vaccination
Jhih-Jian Gao, Hung‐Pin Tseng, Chun-Liang Lin, et al.
Vaccines (2021) Vol. 9, Iss. 9, pp. 1008-1008
Open Access | Times Cited: 60
A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant
Mengxin Zhang, Ying Liang, Dongsheng Yu, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 2, pp. 889-900
Open Access | Times Cited: 60
Page 1 - Next Page

Scroll to top